2-丙酰基苯甲腈 | 6955-26-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-丙酰基苯甲腈
• 英文名称: 2-propanoylbenzonitrile
• CAS: 6955-26-6
• 化学式: C₁₀H₉NO
• 分子量: 159.188
• InChiKey: RHWZMPUGKUQVIH-UHFFFAOYSA-N

物化性质

• 熔点：
  45-48 °C(Solv: ethyl ether (60-29-7); hexane (110-54-3))
• 沸点：
  297.9±23.0 °C(Predicted)
• 密度：
  1.08

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  40.9
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-丙酰基苯甲腈 在 吡啶 、 magnesium bis(N,N-diisopropylamide) 作用下， 以 乙醚 为溶剂， 生成 (Z)-3-acetylamino-3-[2-(1-ethylvinyl)phenyl]-N,N-dimethylpropenamide
  参考文献：
  名称：

  Synthesis of (Z)-2-(2H-Isoquinolin-1-ylidene)acetamides by Iodine-Mediated Cyclization of (Z)-3-Amino-3-(2-vinylphenyl)propenamides

  摘要：

  (Z)-2-(2-乙酰基-2H-异喹啉-1-亚基)乙酰胺已通过三步法从2-乙烯基苯甲腈衍生物合成。关键步骤涉及碘介导的(Z)-3-乙酰氨基-3-(2-乙烯基苯基)丙烯酰胺的6-endo环化反应，这些化合物是通过2-乙烯基苯甲腈与叔胺的镁烯醇盐缩合，随后进行N-乙酰化反应制备的。

  DOI：

  10.1055/s-2007-965934
• 作为产物：
  描述：

  1-(2-溴苯基)丙烷-1-酮 、 氰化亚铜 以 N,N-二甲基甲酰胺 为溶剂， 反应 0.5h， 以52%的产率得到2-丙酰基苯甲腈
  参考文献：
  名称：

  Synthesis of (Z)-2-(2H-Isoquinolin-1-ylidene)acetamides by Iodine-Mediated Cyclization of (Z)-3-Amino-3-(2-vinylphenyl)propenamides

  摘要：

  (Z)-2-(2-乙酰基-2H-异喹啉-1-亚基)乙酰胺已通过三步法从2-乙烯基苯甲腈衍生物合成。关键步骤涉及碘介导的(Z)-3-乙酰氨基-3-(2-乙烯基苯基)丙烯酰胺的6-endo环化反应，这些化合物是通过2-乙烯基苯甲腈与叔胺的镁烯醇盐缩合，随后进行N-乙酰化反应制备的。

  DOI：

  10.1055/s-2007-965934

文献信息

• Bicyclic Pyrrole Derivatives
  申请人：Nakahira Hiroyuki

  公开号：US20080318922A1

  公开（公告）日：2008-12-25

  Compounds represented by the general formula (I), prodrugs thereof, or pharmaceutically acceptable salts of both are provided as compounds which have high DPP-IV inhibiting activity and are improved in safety, toxicity and so on: (I) wherein the solid line and dotted line between A 1 and A 2 represents a double bond (A 1 =A 2 ) or the like; A 1 is C(R 4 ) or the like; A 2 is nitrogen atom or the like; R 1 is hydrogen atom, optionally substituted alkyl group, or the like; R 2 is hydrogen atom, optionally substituted alkyl group, or the like; R 3 is hydrogen atom, halogen atom, or the like; R 4 is hydrogen atom, hydroxyl, halogen atom, or the like; and Y is a group represented by the general formula (A) or the like; (A) [wherein m1 is 0, 1, 2 or 3; and the group (A) may be freed from R 6 or substituted with one or two R 6 's which are each independently halogen atom or the like.]

  提供了一种通式(I)、其前药或两者的药物可接受盐作为具有高DPP-IV抑制活性并在安全性、毒性等方面得到改进的化合物：(I)其中A1和A2之间的实线和虚线表示双键(A1=A2)或类似物；A1是C(R4)或类似物；A2是氮原子或类似物；R1是氢原子、可选取代烷基或类似物；R2是氢原子、可选取代烷基或类似物；R3是氢原子、卤原子或类似物；R4是氢原子、羟基、卤原子或类似物；Y是由通式(A)或类似物表示的基团；(A)[其中m1为0、1、2或3；基团(A)可以从R6中释放或用一个或两个R6替代，它们各自独立地是卤原子或类似物。]
• Novel condensed imidazole derivative
  申请人：Nakahira Hiroyuki

  公开号：US20070105890A1

  公开（公告）日：2007-05-10

  Disclosed is a compound represented by the formula (1) below which has a high DPP-IV inhibitory activity and is improved in safety, toxicity and the like. Also disclosed is a prodrug of such a compound and pharmaceutically acceptable salts of them. (In the formula, R 1 represents a hydrogen atom, an optionally substituted alkyl group or the like; R 2 and R 3 independently represent a hydrogen atom, an optionally substituted alkyl group or the like; R 4 and R 5 independently represent a hydrogen atom, an optionally substituted alkyl group or the like: R 6 represents a hydrogen atom, an optionally substituted aryl group or the like; and —Y—NH 2 , represents a group represented by the following formula (A): (wherein m is 0, 1 or 2; and R 7 may not exist or one or two R 7 may exist and independently represent an optionally substituted alkyl group or the like) or the like.]

  公开了一种化合物，其表示为以下式（1），具有较高的DPP-IV抑制活性并且在安全性、毒性等方面得到改善。还公开了这种化合物的前药和它们的药学上可接受的盐。（在该式中，R1表示氢原子，可选择性取代的烷基或类似物; R2和R3独立地表示氢原子，可选择性取代的烷基或类似物; R4和R5独立地表示氢原子，可选择性取代的烷基或类似物：R6表示氢原子，可选择性取代的芳基或类似物; 而—Y—NH2表示由以下式（A）表示的基团：（其中m为0、1或2；而R7可能不存在或一个或两个R7可能存在且独立地表示可选择性取代的烷基或类似物）或类似物。）
• BICYCLIC PYRROLE DERIVATIVES
  申请人：Nakahira Hiroyuki

  公开号：US20090149483A1

  公开（公告）日：2009-06-11

  Compounds represented by the general formula (I), prodrugs thereof, or pharmaceutically acceptable salts of both are provided as compounds which have high DPP-IV inhibiting activity and are improved in safety, toxicity and so on: (I) wherein the solid line and dotted line between A 1 and A 2 represents a double bond (A 1 =A 2 ) or the like; A 1 is C(R 4 ) or the like; A 2 is nitrogen atom or the like; R 1 is hydrogen atom, optionally substituted alkly group, or the like; R 2 is hydrogen atom, optionally substituted alkyl group, or the like; R 3 is hydrogen atom, halogen atom, or the like; R 4 is hydrogen atom, hydroxyl, halogen atom, or the like; and Y is a group represented by the general formula (A) or the like; (A) [wherein m1 is 0, 1, 2 or 3; and the group (A) may be freed from R 6 or substituted with one or two R 6 's which are each independently halogen atom or the like.]

  提供了一种通式(I)、其前药或其药学上可接受的盐，作为具有高DPP-IV抑制活性并在安全性、毒性等方面得到改善的化合物：(I)，其中A1和A2之间的实线和虚线表示双键(A1=A2)或类似结构；A1是C(R4)或类似结构；A2是氮原子或类似结构；R1是氢原子、可选择性取代的烷基或类似结构；R2是氢原子、可选择性取代的烷基或类似结构；R3是氢原子、卤素原子或类似结构；R4是氢原子、羟基、卤素原子或类似结构；Y是由通式(A)或类似结构表示的基团；(A)中，m1为0、1、2或3；且基团(A)可能从R6中解放出来，或被一个或两个独立的R6取代，这些R6分别是卤素原子或类似结构。
• COMPOUNDS
  申请人：Baeschlin Daniel Kaspar

  公开号：US20090192138A1

  公开（公告）日：2009-07-30

  The invention provides novel deazaxanthine and deazahypoxanthine compounds. The compounds may be useful in the therapy of diseases and conditions in which dipeptidylpeptidase-IV (DPP-IV) is implicated.

  本发明提供了新型的脱氮黄质和脱氮次黄嘌呤化合物。这些化合物可用于治疗与二肽基肽酶-IV（DPP-IV）有关的疾病和病况。
• US7601728B2
  申请人：——

  公开号：US7601728B2

  公开（公告）日：2009-10-13